I am giving a presentation at a cardio-oncology conference on the topic of monitoring oncology patients with normal cardiac function—specifically, when the cardiologist should be notified. Please find key, targeted information based on guidelines and recent publications to help me prepare a 12-minute talk. I would like the information to be well-structured and academically sound, complete with relevant references.
I am giving a presentation at a cardio-oncology conference on the topic of monitoring oncology patients with normal cardiac function—specifically, when the cardiologist should be notified. Please find key, targeted information based on guidelines and recent publications to help me prepare a 12-minute talk. I would like the information to be well-structured and academically sound, complete with relevant references.
Created using ChatSlide
This framework outlines a comprehensive approach to managing cardiac risks in patients. It emphasizes the need to define CTRCD beyond baseline LVEF, stratify risks based on therapy, patient, and biomarkers, and establish baseline metrics like ECG and troponin levels. Monitoring triggers include acting on symptoms and significant biomarker changes, with a focus on GLS decline as an early warning. A practical pathway is proposed, utilizing a case-based surveillance algorithm and fostering...